Finger-Prick test may predict sepsis severity

NCT ID NCT02180399

Completed Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether measuring lactate from a finger-prick (capillary blood) can help doctors identify sepsis patients who need intensive care. Researchers enrolled 60 adults with signs of sepsis outside the ICU. The goal was to see if this quick, bedside test could catch early metabolic problems better than standard blood tests, potentially guiding treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a faster, simpler way to spot which sepsis patients need intensive care, potentially improving outcomes.
What could go wrong: This is a small, completed study with only 60 participants, so results may not apply widely. The test's accuracy in real-world settings is still uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

infectious disease with sepsis Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SEPSIS

Contacts and locations

Locations

SERVICE DE MED. INTERNE - DIABETE ET MALADIES METABOLIQUES, 1-place de l'Hôpital

Strasbourg, 67091, France
Service de Médecine Interne - Clinique Médicale B

Strasbourg, 67091, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.